BIOMAT Database Logo BIOMAT Database Logo

Stereoselective synthesis of a novel carbocyclic nucleoside. 2001

M K Gurjar, and K Maheshwar
National Chemical Laboratory, Pune 411 008, India. gurjar@dalton.ncl.res.in

UI MeSH Term Description Entries
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D016048 Dideoxyadenosine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is an inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal side effect is nephrotoxicity. In vivo, dideoxyadenosine is rapidly metabolized to DIDANOSINE (ddI) by enzymatic deamination; ddI is then converted to dideoxyinosine monophosphate and ultimately to dideoxyadenosine triphosphate, the putative active metabolite. 2',3'-Dideoxyadenosine,ddA (Antiviral),2',3' Dideoxyadenosine

Related Publications

M K Gurjar, and K Maheshwar
Stereoselective synthesis of carbocyclic analogues of the nucleoside Q precursor (PreQ0).
January 2014, Beilstein journal of organic chemistry,
M K Gurjar, and K Maheshwar
Synthesis of a novel conformationally locked carbocyclic nucleoside ring system.
May 2003, Organic letters,
M K Gurjar, and K Maheshwar
Synthesis of oligonucleotides containing a carbocyclic nucleoside.
January 1995, Nucleic acids symposium series,
M K Gurjar, and K Maheshwar
Synthesis and Anticancer Properties of Novel Truncated Carbocyclic Nucleoside Analogues.
January 2018, Anti-cancer agents in medicinal chemistry,
M K Gurjar, and K Maheshwar
[Synthesis of analogues of carbocyclic nucleoside].
January 1991, Yao xue xue bao = Acta pharmaceutica Sinica,
M K Gurjar, and K Maheshwar
Synthesis and anticancer activities of novel 8-azapurine carbocyclic nucleoside hydrazones.
October 2015, Bioorganic & medicinal chemistry letters,
M K Gurjar, and K Maheshwar
Synthesis of LoganVir, a new carbocyclic nucleoside analogue.
October 2016, Natural product research,
M K Gurjar, and K Maheshwar
Enantioselective synthesis of the carbocyclic nucleoside (-)-abacavir.
March 2012, Organic & biomolecular chemistry,
M K Gurjar, and K Maheshwar
Synthesis of fluorinated carbocyclic pyrimidine nucleoside analogues.
December 2022, Organic & biomolecular chemistry,
M K Gurjar, and K Maheshwar
Transition-metal-mediated synthesis of novel carbocyclic nucleoside analogues with antitumoral activity.
October 2004, Chemistry (Weinheim an der Bergstrasse, Germany),
Copied contents to your clipboard!